力诺药包
(301188)
| 流通市值：42.63亿 | | | 总市值：42.63亿 |
| 流通股本：2.32亿 | | | 总股本：2.32亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 711,089,158.45 | 490,489,588.5 | 582,157,054.75 | 646,887,547.88 |
| 应收票据及应收账款 | 285,618,110.16 | 254,141,166.92 | 275,531,911.82 | 281,527,632.98 |
| 其中：应收票据 | 34,919,394.69 | 46,338,154.47 | 53,455,913.74 | 62,824,508.31 |
| 应收账款 | 250,698,715.47 | 207,803,012.45 | 222,075,998.08 | 218,703,124.67 |
| 应收款项融资 | 27,578,667.56 | 18,140,205.73 | 7,328,352.7 | 9,772,707.99 |
| 预付款项 | 10,834,668.84 | 17,214,368.78 | 13,397,920.85 | 9,377,001.89 |
| 其他应收款合计 | 9,399,900.01 | 9,526,282.49 | 10,871,811.13 | 12,171,788.29 |
| 存货 | 293,192,101.94 | 272,692,308.88 | 245,827,434.43 | 221,988,463.26 |
| 其他流动资产 | 17,159,300.49 | 20,549,550.97 | 1,241,557.63 | 2,173,805.83 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,430,855,873.93 | 1,378,504,057.29 | 1,286,356,043.31 | 1,293,898,948.12 |
| 非流动资产: | | | | |
| 长期股权投资 | 54,268,706.83 | 52,987,357.77 | 53,121,347.63 | 51,445,353.01 |
| 固定资产 | 659,866,383.71 | 667,310,290.12 | 654,304,413.92 | 656,459,612.24 |
| 在建工程 | 165,140,689.37 | 150,111,039.09 | 64,819,950.7 | 44,354,858.18 |
| 使用权资产 | 2,365,674.24 | 2,492,612.67 | 2,646,595.76 | 2,746,489.53 |
| 无形资产 | 69,793,337.66 | 70,296,355.07 | 70,799,217.93 | 71,029,202.11 |
| 长期待摊费用 | 1,131,960.86 | 1,462,240.04 | 7,500,089.92 | 9,354,876.68 |
| 递延所得税资产 | - | - | 3,123,420.12 | 3,084,410.35 |
| 其他非流动资产 | 58,167,243.42 | 32,852,942.37 | 63,984,445.12 | 42,443,821.06 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,010,733,996.09 | 977,512,837.13 | 920,299,481.1 | 880,918,623.16 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,441,589,870.02 | 2,356,016,894.42 | 2,206,655,524.41 | 2,174,817,571.28 |
| 流动负债: | | | | |
| 短期借款 | 15,011,916.67 | 15,011,916.67 | - | - |
| 衍生金融负债 | 198,800 | 198,800 | - | - |
| 应付票据及应付账款 | 302,012,728.2 | 243,013,584.01 | 151,943,903.68 | 151,512,998.93 |
| 其中：应付票据 | 124,337,583.69 | 60,113,564.62 | 20,059,377.84 | 6,225,320 |
| 应付账款 | 177,675,144.51 | 182,900,019.39 | 131,884,525.84 | 145,287,678.93 |
| 合同负债 | 14,346,268.79 | 14,330,492.37 | 17,542,737.2 | 20,822,224.81 |
| 应付职工薪酬 | 12,911,435.98 | 16,163,498.16 | 16,574,849.03 | 16,073,509.48 |
| 应交税费 | 8,390,810.79 | 7,320,255.14 | 9,066,492.62 | 7,415,629.01 |
| 其他应付款合计 | 2,151,108.3 | 1,540,469.78 | 2,404,092.61 | 3,262,618.63 |
| 一年内到期的非流动负债 | 1,885,495.13 | 1,635,319.85 | 618,091.46 | 1,632,359.99 |
| 其他流动负债 | 13,376,981.29 | 37,986,221.82 | 39,217,840.24 | 28,259,573.8 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 370,285,545.15 | 337,200,557.8 | 237,368,006.84 | 228,978,914.65 |
| 非流动负债: | | | | |
| 长期借款 | 27,016,087.5 | - | - | - |
| 应付债券 | 400,545,182.16 | 394,480,609.12 | 388,292,020.46 | 382,298,879.43 |
| 租赁负债 | - | - | 382,773.66 | 377,685.36 |
| 递延收益 | 52,681,892.7 | 53,930,052.05 | 797,605.36 | 1,072,582.93 |
| 递延所得税负债 | 15,084,791.46 | 16,190,708.52 | 21,382,697.31 | 22,862,686.91 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 495,327,953.82 | 464,601,369.69 | 410,855,096.79 | 406,611,834.63 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 865,613,498.97 | 801,801,927.49 | 648,223,103.63 | 635,590,749.28 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 232,450,595 | 232,450,589 | 232,450,451 | 232,450,451 |
| 其他权益工具 | 109,395,785.36 | 109,395,811.13 | 109,396,249.23 | 109,396,249.23 |
| 资本公积 | 798,855,307.08 | 798,855,211.64 | 798,664,729.3 | 798,645,462.96 |
| 减:库存股 | 68,783,327.22 | 50,029,878.04 | 50,025,992.9 | 50,025,992.9 |
| 盈余公积 | 77,949,730.58 | 77,906,705.89 | 71,296,707.67 | 71,296,707.67 |
| 未分配利润 | 426,108,280.25 | 385,636,527.31 | 396,650,276.48 | 377,463,944.04 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,575,976,371.05 | 1,554,214,966.93 | 1,558,432,420.78 | 1,539,226,822 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,575,976,371.05 | 1,554,214,966.93 | 1,558,432,420.78 | 1,539,226,822 |
| 负债和股东权益合计 | 2,441,589,870.02 | 2,356,016,894.42 | 2,206,655,524.41 | 2,174,817,571.28 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |